News from Thursday, January 8, 2026
Articles
Real-World Study Finds Stable Vision After Switch to Ranibizumab Biosimilar
(1/7, Skylar Jeremias, The Center for Biosimilars) reports “...Summarizing the overall findings, the authors concluded that ‘switching from aflibercept to ranibizumab BS effectively maintained disease stability and cytokine balance in eyes with nAMD,’ supporting the biosimilar as ‘a viable and cost-effective alternative for long-term treatment.’” Full
Trump Administration Cannot Proceed with Pilot Drug Rebate Program, US Court Rules
(1/8, Nate Raymond, Reuters) reports “...The Trump administration cannot require hospitals serving low-income Americans to pay full price upfront for the first 10 medications to become subject to Medicare drug price negotiations and wait for rebates, a U.S. appeals court ruled on Wednesday...The judges, all appointees of Democratic former President Joe Biden, pointed to a lack of evidence that the agency considered the impact the program would have on hospitals, who said the plan would saddle them with hundreds of millions of dollars in new costs.” Subscription Required
Press Releases
Verana Health Merges with COTA to Dramatically Expand Scale, Velocity, and Depth of Real-World Data Offerings Across Oncology and Other Specialties
(1/8, Verana Health Press Release) “...Together, the companies will deliver deeper, more clinically rich real-world data and insights, supported by trusted, research-ready evidence designed to meet the rigor required for clinical and regulatory decision-making. This combination helps accelerate the leveraged, multitherapeutic area strategy that Verana Health has successfully delivered on.” Full
Journals
We Hear What You Are Saying: The Development and Design of the Qualitative Interview Feedback Survey (QIFS) for Use in Qualitative Patient-Centered Outcomes Research Studies
Gemma Al-Jassar, MSc, Katja Rudell, PhD, Dorsa Khazaei, MSc
December 2025, Value in Health
Addressing Bias in Indirect Treatment Comparisons: A Framework for Identifying TEMs and PVs
Paige Pierce, MSc, et al.
December 2025, Value in Health
Acetaminophen (Paracetamol) or Opioid Analgesia Added to Ibuprofen for Children’s Musculoskeletal Injury: Two Randomized Clinical Trials
Samina Ali, MD; Terry P. Klassen, MD, MSc; Patricia Candelaria, BScN, et al.
January 8, 2026, JAMA
Reports
White Paper: Do 340B Contract Pharmacies Really “Increase Access” for 340B Patients?
December 30, 2025